These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 24612661
1. Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer. Blazeby JM, Hall E, Aaronson NK, Lloyd L, Waters R, Kelly JD, Fayers P. Eur Urol; 2014 Dec; 66(6):1148-56. PubMed ID: 24612661 [Abstract] [Full Text] [Related]
2. Development and Validation of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Non-muscle Invasive Bladder Cancer: EORTC QLQ-NMIBC24. Park J, Shin DW, Kim TH, Jung SI, Nam JK, Park SC, Hong S, Jung JH, Kim H, Kim WT. Cancer Res Treat; 2018 Jan; 50(1):40-49. PubMed ID: 28279061 [Abstract] [Full Text] [Related]
3. Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer. Ripping TM, Rammant E, Witjes JA, Aaronson NK, van Hemelrijck M, van Hoogstraten LMC, BlaZIB study group, Kiemeney LA, Aben KKH. Health Qual Life Outcomes; 2022 Dec 29; 20(1):171. PubMed ID: 36581934 [Abstract] [Full Text] [Related]
6. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study. Koller M, Shamieh O, Hjermstad MJ, Hornslien K, Young T, Chalk T, Ioannidis G, Harle A, Johnson CD, Tomaszewski KA, Serpentini S, Pinto M, van der Weijst L, Janssens A, Morag O, Chie WC, Arraras JI, Pompili C, Jungraithmayr W, Hechtner M, Katsochi D, Müller K, Gräfenstein L, Schulz C, Bottomley A, European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group, EORTC Lung Cancer Group, European Society of Thoracic Surgeons. Lancet Oncol; 2020 May 29; 21(5):723-732. PubMed ID: 32213338 [Abstract] [Full Text] [Related]
7. The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review. Rammant E, Fox L, Beyer K, Aaronson NK, Chaloner R, De Padova S, Liedberg F, Wintner LM, Decaestecker K, Fonteyne V, Perdek N, Wylie H, Catto JWF, Ripping TM, Holzner B, Van Leeuwen M, Van Hemelrijck M, EORTC Quality of Life Group. Qual Life Res; 2023 Aug 29; 32(8):2127-2135. PubMed ID: 36648569 [Abstract] [Full Text] [Related]
8. International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18. Chie WC, Blazeby JM, Hsiao CF, Chiu HC, Poon RT, Mikoshiba N, Al-Kadhimi G, Heaton N, Calara J, Collins P, Caddick K, Costantini A, Vilgrain V, Trinquart L, Chiang C, EORTC Quality of Life Group. Hepatology; 2012 Apr 29; 55(4):1122-9. PubMed ID: 22105642 [Abstract] [Full Text] [Related]
9. Psychometric validation of the European Organisation for Research and Treatment of Cancer-Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22). Greimel E, Nagele E, Lanceley A, Oberguggenberger AS, Nordin A, Kuljanic K, Arraras JI, Wei-Chu C, Jensen PT, Tomaszewski KA, Creutzberg CL, Galalae R, Toelen H, Zimmermann K, Bjelic-Radisic V, Costantini A, Almont T, Serpentini S, Paskeviciute Frøding L, Vistad I, Schmalz C, EORTC Quality of Life Group. Eur J Cancer; 2021 Sep 29; 154():235-245. PubMed ID: 34298374 [Abstract] [Full Text] [Related]
13. An international field study for the reliability and validity of the EORTC communication questionnaire EORTC QLQ-COMU26. Arraras JI, Giesinger J, Shamieh O, Bahar I, Koller M, Bredart A, Costantini A, Greimel E, Sztankay M, Wintner LM, de Sousa MC, Ishiki H, Kontogianni M, Wolan M, Kikawa Y, Lanceley A, Gioulbasanis I, Harle A, Zarandona U, Kulis D, Kuljanic K, European Organisation for Research, Treatment of Cancer (EORTC) Quality of Life Group. Health Qual Life Outcomes; 2024 Oct 10; 22(1):87. PubMed ID: 39385305 [Abstract] [Full Text] [Related]
15. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia. Araya LT, Gebretekle GB, Gebremariam GT, Fenta TG. Health Qual Life Outcomes; 2019 Jan 14; 17(1):13. PubMed ID: 30642359 [Abstract] [Full Text] [Related]
16. A large scale prospective clinical and psychometric validation of the EORTC colorectal (QLQ-CR29) module in Polish patients with colorectal cancer. Sanna B, Bereza K, Paradowska D, Kucharska E, Tomaszewska IM, Dudkiewicz Z, Golec J, Bottomley A, Tomaszewski KA. Eur J Cancer Care (Engl); 2017 Nov 14; 26(6):. PubMed ID: 28497549 [Abstract] [Full Text] [Related]
18. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Blazeby JM, Conroy T, Bottomley A, Vickery C, Arraras J, Sezer O, Moore J, Koller M, Turhal NS, Stuart R, Van Cutsem E, D'haese S, Coens C, European Organisation for Research and Treatment of Cancer Gastrointestinal and Quality of Life Groups. Eur J Cancer; 2004 Oct 14; 40(15):2260-8. PubMed ID: 15454251 [Abstract] [Full Text] [Related]
20. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20). Oerlemans S, Efficace F, Kyriakou C, Freitas AC, Shamieh O, Creutzberg CL, Lehmann J, Petranovic D, Nagele E, Bredart A, Dong D, Scholz CW, Caocci G, Molica S, Griskevicius L, Xochelli A, Kieffer JM, Agelink van Rentergem JA, Alrjoub W, Mueller A, Gomes Da Silva M, Alves da Costa F, Malak S, Cocks K, van de Poll-Franse LV, EORTC Quality of Life Group. Cancer; 2023 Sep 01; 129(17):2727-2740. PubMed ID: 37204189 [Abstract] [Full Text] [Related] Page: [Next] [New Search]